Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease

被引：2
|
作者：
Patel, Bansri M. [1 ]
Ramos Rivers, Claudia [2 ]
Koutroumpakis, Filippos [2 ]
Ahsan, Maaz [1 ]
Dueker, Jeffrey [2 ]
Hashash, Jana [2 ]
Johnston, Elyse [2 ]
Barrie, Arthur [2 ]
Harrison, Janet [2 ]
Schwartz, Marc [2 ]
Babichenko, Dmitriy [2 ]
Tang, Gong [2 ]
Binion, David [2 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
来源：
INFLAMMATORY BOWEL DISEASES | 2021年 / 27卷 / 10期
关键词：
cutaneous Crohn's disease; ustekinumab; biologic therapy; anti-TNF therapy; dermatologic manifestation;
D O I：
10.1093/ibd/izab115
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E124 / E124
页数：1
相关论文
共 50 条
  • [31] Ustekinumab for Treatment of Refractory Pyoderma Gangrenosum in a Crohn's Disease Patient
    Groudan, Kevin
    Singhania, Rohit
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1032 - S1032
  • [32] Case Series: Ustekinumab Use in Metastatic Cutaneous Crohn's Disease
    Zullow, Samantha
    Lichtman, Michael K.
    Larson, Allison
    Stier, Elizabeth A.
    Farraye, Francis A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1102 - S1102
  • [33] Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn's disease
    Hanzel, Jurij
    Kozelj, Matic
    Spes Hlastec, Ana
    Kurent, Tina
    Sever, Nejc
    Zdovc, Jurij
    Smrekar, Natasa
    Novak, Gregor
    Stabuc, Borut
    Grabnar, Iztok
    Drobne, David
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E831 - E836
  • [34] Ustekinumab for Crohn's disease
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (01): : 9 - 9
  • [35] Improved Remission with Proactive Therapeutic Drug Monitoring of Ustekinumab for Crohn's Disease
    Shahab, Omer
    Sterling, Richard
    Gaidos, Jill
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S453 - S453
  • [36] Ustekinumab for refractory paediatric Crohn's disease: experience from two UK tertiary referral centres
    Rao, R.
    Gadhok, R.
    Whitley, L.
    Burgess, N.
    Amon, P.
    Naik, S.
    Lindsay, J.
    McCartney, S.
    Kok, K.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S424 - S425
  • [37] USTEKINUMAB FOR REFRACTORY CROHN'S DISEASE (CD) IN ADOLESCENTS: EXPERIENCE FROM TWO UK IBD CENTRES
    Gadhok, Radha
    Rao, Rohit
    Harpham-Lockyer, Louis
    Kwok, Hanson
    Whitley, Lisa
    Ibarra, Ana
    Burgess, Natasha
    McCartney, Sara
    Kok, Klaartje
    [J]. GUT, 2019, 68 : A75 - A75
  • [38] Remission of refractory metastatic Crohn's disease achieved with dapsone
    Guglielmetti, Antonio
    Gompertz, Matias
    Jahr, Catalina
    Silva, Tomas
    Gonzalez, Sergio
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (04) : 467 - 469
  • [39] Treatment of Rituximab-induced Crohn's Disease With Ustekinumab Induction and Long-term Maintenance of Remission
    Shankar, Uday
    Vijayasekar, Kavitha
    Bansal, Raghav
    Walfish, Aaron
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : E3 - E3
  • [40] Use of Ustekinumab in Pediatric Crohn's Disease: A Report of Three Cases
    Sarles, Harry E., Jr.
    Whitney, Annette E.
    Van Anglen, Lucinda J.
    Kuten, Samantha A.
    Hardin, Thomas C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1383 - S1383
12345